Researchers investigated whether ipamorelin, a growth hormone-releasing peptide, could stimulate longitudinal bone growth in a rat model. The study found that ipamorelin induced increases in longitudinal bone growth in treated rats. This evidence comes from animal model research and does not directly demonstrate effects in humans.